BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1918496)

  • 1. Differences in clinical, serologic, and immunogenetic features of white versus Oriental anti-SS-A/Ro-positive patients.
    Nishikawa T; Provost TT
    J Am Acad Dermatol; 1991 Sep; 25(3):563-4. PubMed ID: 1918496
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-Ro(SS-A) HLA-DR3-positive women: the interrelationship between some ANA negative, SS, SCLE, and NLE mothers and SS/LE overlap female patients.
    Provost TT; Watson R
    J Invest Dermatol; 1993 Jan; 100(1):14S-20S. PubMed ID: 8423383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-Ro antibody system.
    Hymes SR; Russell TJ; Jordon RE
    Int J Dermatol; 1986; 25(1):1-7. PubMed ID: 3512458
    [No Abstract]   [Full Text] [Related]  

  • 4. Ro(SS-A) positive Sjogren's/lupus erythematosus (SC/LE) overlap patients are associated with the HLA-DR3 and/or DRw6 phenotypes.
    Provost TT; Talal N; Bias W; Harley JB; Reichlin M; Alexander EL
    J Invest Dermatol; 1988 Oct; 91(4):369-71. PubMed ID: 3262691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, serological, and HLA phenotype subsets in Sjögren's syndrome.
    Pease CT; Shattles W; Charles PJ; Venables PJ; Maini RN
    Clin Exp Rheumatol; 1989; 7(2):185-90. PubMed ID: 2786788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of Ro (SS-A) and La (SS-B) antibodies in lupus erythematosus.
    Provost TT
    Semin Dermatol; 1988 Jun; 7(2):130-9. PubMed ID: 3153434
    [No Abstract]   [Full Text] [Related]  

  • 7. Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren's syndrome.
    Ben-Chetrit E; Fox RI; Tan EM
    Arthritis Rheum; 1990 Mar; 33(3):349-55. PubMed ID: 2107806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, serological and immunogenetic features of Japanese anti-Ro/SS-A-positive patients with annular erythema.
    Miyagawa S
    Dermatology; 1994; 189 Suppl 1():11-3. PubMed ID: 8049546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of antibodies to Ro/SS-A and La/SS-B in subacute cutaneous lupus erythematosus and related conditions.
    Zappi E; Sontheimer R
    Immunol Invest; 1993 Apr; 22(3):189-203. PubMed ID: 8509157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic studies of Ro (SS-A) and La (SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjögren's syndrome.
    Arnett FC; Hamilton RG; Reveille JD; Bias WB; Harley JB; Reichlin M
    Arthritis Rheum; 1989 Apr; 32(4):413-9. PubMed ID: 2706027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Ro in Sjögren's syndrome and systemic lupus erythematosus.
    Harley JB; Scofield RH; Reichlin M
    Rheum Dis Clin North Am; 1992 May; 18(2):337-58. PubMed ID: 1626073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of HLA class II genes and autoimmune responses to Ro/SS-A-La/SS-B among Japanese subjects.
    Miyagawa S; Shinohara K; Nakajima M; Kidoguchi K; Fujita T; Fukumoto T; Yoshioka A; Dohi K; Shirai T
    Arthritis Rheum; 1998 May; 41(5):927-34. PubMed ID: 9588746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluctuation of anti-Ro/SS-A antibody levels in patients with systemic lupus erythematosus and Sjögren's syndrome: a prospective study.
    Praprotnik S; Bozic B; Kveder T; Rozman B
    Clin Exp Rheumatol; 1999; 17(1):63-8. PubMed ID: 10084034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. U1RNP antibody-positive neonatal lupus. A report of two cases with immunogenetic studies.
    Dugan EM; Tunnessen WW; Honig PJ; Watson RM
    Arch Dermatol; 1992 Nov; 128(11):1490-4. PubMed ID: 1444503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialographic study in patients with and without antibodies to Sjögren's syndrome A (Ro).
    Miyachi K; Naito M; Maeno Y; Suzuki S; Hamamoto T; Sugiura M; Kasahara M; Torikai K; Umeda H
    J Rheumatol; 1983 Jun; 10(3):387-94. PubMed ID: 6604159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody.
    Hamilton RG; Harley JB; Bias WB; Roebber M; Reichlin M; Hochberg MC; Arnett FC
    Arthritis Rheum; 1988 Apr; 31(4):496-505. PubMed ID: 2451920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C2 deficient systemic lupus erythematosus: its association with anti-Ro (SSA) antibodies.
    Vandersteen PR; Provost TT; Jordon RE; McDuffie FC
    Arch Dermatol; 1982 Aug; 118(8):584-7. PubMed ID: 6980631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Ro/SS-A antigen-antibody system].
    Mayet WJ; Bachmann M; Hermann E; Poralla T; Müller WE; Meyer zum Büschenfelde KH
    Z Rheumatol; 1988; 47(2):80-5. PubMed ID: 3291481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ro/SS-A and the pathogenic significance of its antibodies.
    McCauliffe DP; Lux FA; Lieu TS; Sanz I; Hanke J; Newkirk MM; Siciliano MJ; Sontheimer RD; Capra JD
    J Autoimmun; 1989 Aug; 2(4):375-81. PubMed ID: 2477003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HLA antigens in patients with Sjögren's syndrome].
    Moutsopoulos HM; Papasteriades CA; Skopouli FN; Drosos AA
    Ter Arkh; 1988; 60(4):28-30. PubMed ID: 3260692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.